Fresh Recalls

FDAClass III · Drug · Recall D-0654-2026 · Recalled July 8, 2026

Fexofenadine Hydrochloride Tablets recall — SUN PHARMACEUTICAL INDUSTRIES INC

Agency report date: July 8, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Fexofenadine Hydrochloride Tablets
Company / brand
SUN PHARMACEUTICAL INDUSTRIES
Lot / serial / date codes
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
Distribution
U.S. Nationwide
Agency product description and boundaries

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Impurities/Degradation Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: Fexofenadine Hydrochloride Tablets

3. Open the official notice or contact

Official recall ID
D-0654-2026
Brand
SUN PHARMACEUTICAL INDUSTRIES
Classification
Class III
Units affected
9,048 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Princeton, NJ, United States
Firm address
2 Independence Way, N/A, 08540-6620

Identifying details (verbatim from the notice)

Product codes / lots
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
Distribution
U.S. Nationwide
Firm notified the public via
Letter
FDA event ID
99110
Recall initiated
June 1, 2026
FDA classified
June 30, 2026
FDA report date
July 8, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page